BAYER AG - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:800-900
Total Number of Projects:400-500
2019
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:> 1000
Total Number of Projects:200-300
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):800-900
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:800-900
Total Number of Projects:66
Total Project Funding:600-700
Networking Rank (Reputation):300-400
Networking Rank (Reputation):300-400
Partner Constancy:46
Project Leadership Index:75
Diversity Index:41
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
Diversity Index:700-800
2010
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:300-400
Total Number of Projects:400-500
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:500-600
Project Leadership Index:600-700
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Total Project Funding:200-300
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:300-400
Diversity Index:400-500
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:500-600
Project Leadership Index:500-600
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2021-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 106
As coordinator: 1
As participant: 104
Sole participant: 1
Coordinator / Participant Ratio: 0.01*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 105.786.635 2.245.107 11
2020 0 105.103.504 0 7
2019 0 119.550.151 104.388 13
2018 0 158.450.518 529.687 15
2017 0 110.809.331 0 8
2016 172.800 25.019.666 0 1 3
2015 5.997.550 24.228.670 1.175.350 1 7
2014 0 7.794.899 400.000 2
2013 0 42.834.903 715.041 9
2012 0 32.826.256 603.207 7
2011 0 41.526.048 309.422 10
2010 0 75.369.716 3.898.684 12

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED19
NOVARTIS PHARMA18
JANSSEN PHARMACEUTICA NV17
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V15
ASTRAZENECA14
SANOFIAVENTIS14
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE13
KATHOLIEKE UNIVERSITEIT LEUVEN13
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD12
UCB BIOPHARMA11
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG10
F HOFFMANNLA ROCHE10
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT10
ELI LILLY AND COMPANY LIMITED9
TAKEDA PHARMACEUTICALS INTERNATIONAL9
KAROLINSKA INSTITUTE8
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN8
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS7
VTT TECHNICAL RESEARCH CENTRE OF FINLAND7
ABBVIE INC6
ASTELLAS PHARMA EUROPE BV6
FORUM DES PATIENTS EUROPEENS6
NOVO NORDISK6
UNIVERSITAIR MEDISCH CENTRUM UTRECHT6
UNIVERSITEIT UTRECHT6
UNIVERSITY COLLEGE LONDON6
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE5
CHARITE UNIVERSITAETSMEDIZIN BERLIN5
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
STICHTING LYGATURE5
TAKEDA DEVELOPMENT CENTRE EUROPE5
UNIVERSITAT WIEN5
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN5
UNIVERSITY OF COPENHAGEN5
CELGENE MANAGEMENT SARL4
COMMISSARIAT A L'ENERGIE ATOMIQUE4
CONSIGLIO NAZIONALE DELLE RICERCHE4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
GOETEBORGS UNIVERSITET4
GRUNENTHAL4
INSTITUT DE RECHERCHES SERVIER4
LEIDEN UNIVERSITY4
MEDIZINISCHE UNIVERSITAET WIEN4
NEDERLANDSE ORGANISATIE VOOR TOEGEPAST NATUURWETENSCHAPPELIJK ONDERZOEK TNO4
OSPEDALE PEDIATRICO BAMBINO GESU4
STICHTING VUMC4
THE UNIVERSITY OF LIVERPOOL4
TTOPSTART BV4
UNIVERSITEIT MAASTRICHT4
UNIVERSITY COLLEGE CORK NATIONAL UNIVERSITY OF IRELAND CORK4
UNIVERSITY OF BIRMINGHAM4
UNIVERSITY OF CAMBRIDGE4
UNIVERSITY OF DUNDEE4
UNIVERSITY OF LEEDS4
UNIVERSITY OF NEWCASTLE UPON TYNE4
UPPSALA UNIVERSITET4
VRIJE UNIVERSITEIT BRUSSEL4
AMGEN LIMITED3
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL3
DANMARKS TEKNISKE UNIVERSITET3
DEGUSSA3
DEUTSCHES KREBSFORSCHUNGSZENTRUM3
EUROPEAN CANCER PATIENT COALITION3
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE3
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL3
FORSCHUNGSZENTRUM JULICH3
GENOME RESEARCH3
HELSINGIN JA UUDENMAAN SAIRAANHOITOPIIRIN KUNTAYHTYMAE3
KING'S COLLEGE LONDON3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
LUND UNIVERSITY3
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV3
MERCK SHARP & DOHME CORP3
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE3
OWKIN FRANCE3
SERVICIO MADRILENO DE SALUD3
SIB INSTITUT SUISSE DE BIOINFORMATIQUE3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
STICHTING RADBOUD UNIVERSITEIT3
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL3
TARTU ULIKOOL3
TECHNISCHE UNIVERSITAET MUENCHEN3
TECHNISCHE UNIVERSITEIT EINDHOVEN3
TEVA PHARMACEUTICAL INDUSTRIES LIMITED3
THE HYVE BV3
THE UNIVERSITY OF MANCHESTER3
THE UNIVERSITY OF WARWICK3
UNIVERSIDAD DE NAVARRA3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITE D'AIX MARSEILLE3
UNIVERSITE DU LUXEMBOURG3
UNIVERSITEIT GENT3
UNIVERSITY OF BOLOGNA3
WEIZMANN INSTITUTE OF SCIENCE3
ACADEMISCH ZIEKENHUIS GRONINGEN2
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
ARTTIC2

Constancy:

Total number of partners: 1302
Partner loyalty:
Frequent Partner: (> 2 projects): 517
Rare Partner: 785
Frequent / Rare Partner Ratio: 0.66

Project overview:

Start dateProjectacronymrolefundingpartners
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-06-01Add medical genetic solutions to RESOLUTE (REsolution) REsolutionparticipant1.000.0009
2021-06-01RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs RISK-HUNT3Rparticipant22.927.76938
2021-05-01Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment ONTOXparticipant17.211.05018
2021-03-01European Network Linking Informatics and Genomics of Helper T cells in Tissues ENLIGHT-TENplusparticipant4.067.52615
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82548
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2021-01-01Advanced machine learning for Innovative Drug Discovery AIDDparticipant3.926.61515
2021-01-01Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials SISAQOL-IMIparticipant2.281.84033
2021-01-01Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population AGePOPparticipant2.790.4436
2021-01-01A fully integrated, animal-free, end-to-end modelling approach to oral drug product development InPharmaparticipant3.475.40211
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-11-01Gravitate–Health: Empowering and Equipping Europeans with health information for Active Personal Health Management and Adherence to Treatment Gravitate-Healthparticipant9.280.00040
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-09-01Prioritisation and Risk Evaluation of Medicines in the EnviRonment PREMIERparticipant4.550.00025
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2020-01-01PharmaLedger PharmaLedgerparticipant8.290.69429
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Collaboration for innovation: Establishment of a pan-nematode drug development platform HELPparticipant8.713.3958
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-07-01Health.E Lighthouse Support Initiative HELoSparticipant499.4798
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-03-01A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies V.A. Cureparticipant3.792.13617
2019-03-01Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts IMMUcanparticipant17.830.00028
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01A European standardization framework for data integration and data-driven in silico models for personalized medicine EU-STANDS4PMparticipant2.042.41116
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabparticipant18.249.99320
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-09-01Ensuring the future of EUPATI beyond 2020 EFOEUPATIparticipant365.24312
2018-09-01Quantitative T cell Immunology and Immunotherapy QuanTIIparticipant3.923.65311
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2018-06-01The GetReal Initiative GetReal Initiativeparticipant1.750.00017
2018-05-01RustWatch: A European early-warning system for wheat rust diseases RUSTWATCHparticipant4.999.99925
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034
2018-05-01Integrated control and sensing platform for biopharmaceutical cultivation process high-throughput development and production iConsensusparticipant4.700.00019
2018-05-01conect4children (COllaborative Network for European Clinical Trials For Children) c4cparticipant67.000.00047
2018-04-01Improving the care of patients suffering from acute or chronic pain IMI-PainCareparticipant11.225.27140
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2018-01-01Meiotic Control of Recombination in Crops MEICOMparticipant3.107.82019
2018-01-01Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease CaReSyAnparticipant2.795.34615
2018-01-01Super-resolution optical microscopy of nanosized pore dynamics in endothelial cells DeLIVERparticipant3.728.51314
2017-09-01Develop and validate appropriate and acceptable outcome measures in intermediate age-related macular degeneration for future interventional clinical trials - Sofia ref.: 116076 MACUSTARparticipant8.025.00013
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-03-01Big Data 4 Better Hearts - Sofia ref.: 116074 BigData Heartparticipant9.664.97019
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336

overview shows latest 50 from 106 projects (2010-01-01 - 2021-12-31)
A full list of projects can be found here:

Alias institution names:

  • BAYER
  • BAYER
  • BAYER AKTIENGESELLSCHAFT
  • BAYER BIOSCIENCE NV
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE
  • BAYER CROPSCIENCE BIOLOGICS
  • BAYER CROPSCIENCE NV
  • BAYER MATERIALSCIENCE
  • BAYER PHARMA
  • BAYER SAS
  • BAYER SCHWEIZ
  • BAYER TECHNOLOGY SERVICES